drugset / Trial / NCT01235715

The Use of Evicel to Reduce Blood Loss in Total Knee Replacement Surgery

NCT01235715

RandomizedParallel-groupTriple-blindPrevention

Summary

Application of "Evicel" hemostatic matrix during operation for unilateral total knee replacement surgery (TKA) will result in decreased bleeding and postoperative drain output, a reduction in transfusion requirements, and less reduction of hemoglobin.

Timeline

Start
2010-09
Primary completion
2012-03
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fibrinogen Concentrate Human Protein / enzyme biologic

Indications